{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:03:36Z","timestamp":1775581416042,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Health Serv."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The strategies to control scabies in highly endemic populations include individual case\/household management and mass drug administration (MDA). We used a decision-analytic model to compare ivermectin-based MDA and individual case\/household management (referred to as \u201cusual care\u201d) for control of scabies in Ethiopia at different prevalence thresholds for commencing MDA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A decision-analytic model was based on a repeated population survey conducted in Northern Ethiopia in 2018\u20132020, which aimed to evaluate the secondary impact of single-dose ivermectin MDA for the control of onchocerciasis on scabies prevalence. The model estimates the number of scabies cases and costs of two treatment strategies (MDA and usual care) based on their effectiveness, population size, scabies prevalence, compliance with MDA, medication cost, and other parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the base-case analysis with a population of 100,000 and scabies prevalence of 15%, the MDA strategy was both more effective and less costly than usual care. The probability of MDA being cost-effective at the current cost-effectiveness threshold (equivalent to the cost of usual care) was 85%. One-way sensitivity analyses showed that the MDA strategy remained dominant (less costly and more effective) in 22 out of 26 scenarios. MDA was not cost-effective at scabies prevalence &amp;lt;10%, MDA effectiveness &amp;lt;85% and population size &amp;lt;5,000. An increase in the cost of ivermectin from 0 (donated) to 0.54 US$\/dose resulted in a decrease in the probability of MDA being cost-effective from 85% to 17%. At 0.25 US$\/dose, the MDA strategy was no longer cost-effective.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The model provides robust estimates of the costs and outcomes of MDA and usual care and can be used by decision-makers for planning and implementing scabies control programmes. Results of our analysis suggest that single-dose ivermectin MDA is cost-effective in scabies control and can be initiated at a scabies prevalence &amp;gt;10%.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frhs.2024.1279762","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:56:49Z","timestamp":1726649809000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Cost-effectiveness of mass drug administration for control of scabies in Ethiopia: a decision-analytic model"],"prefix":"10.3389","volume":"4","author":[{"given":"Natalia","family":"Hounsome","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robel","family":"Yirgu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie A.","family":"Cassell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abebaw","family":"Fekadu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Davey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"B1","article-title":"Scabies","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","article-title":"The global burden of scabies: a cross-sectional analysis from the global burden of disease study 2015","volume":"17","author":"Karimkhani","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/146642407709700112","article-title":"Scabies in 1976","volume":"97","author":"Mellanby","year":"1977","journal-title":"R Soc Health J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jaad.2019.05.109","article-title":"Ectoparasites: scabies","volume":"82","author":"Thomas","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.23880\/eij-16000273","article-title":"Systematic review of institutional scabies outbreaks in sub saharan Africa","volume":"7","author":"Akinde","year":"2023","journal-title":"Epidemiol Int J"},{"key":"B6","article-title":"Scabies Outbreak Preparedness and Response Plan. December 2015. OCHA Services. Humanitarian Response","year":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/tropicalmed3040114","article-title":"Investigation of a scabies outbreak in drought-affected areas in Ethiopia","volume":"3","author":"Enbiale","year":"2018","journal-title":"Trop Med Infect Dis"},{"key":"B8","article-title":"Scabies outbreak investigation in Addet town, West Gojjam Zone, Amhara region, Northwest Ethiopia, 2017","author":"Alebachew","year":""},{"key":"B9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12879-020-05106-3","article-title":"Prevalence and associated factors of scabies in Ethiopia: systematic review and meta-analysis","volume":"20","author":"Azene","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"28S","DOI":"10.3855\/jidc.11701","article-title":"\u201cStopping the itch\u201d: mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia","volume":"14","author":"Enbiale","year":"2020","journal-title":"J Infect Dev Countries"},{"key":"B11","article-title":"WHO informal consultation on a framework for scabies control: World Health Organization Regional Office for the Western Pacific: Manila, Philippines, 19\u201321 February 2019: meeting report","year":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0009661","DOI":"10.1371\/journal.pntd.0009661","article-title":"A framework for scabies control","volume":"15","author":"Engelman","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"B13","article-title":"Second Edition of National Neglected Tropical Diseases Master Plan for Ethiopia, 2016","year":""},{"key":"B14","article-title":"Guidelines for onchocerciasis elimination in Ethiopia","year":"2015"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e075038","DOI":"10.1136\/bmjopen-2023-075038","article-title":"Scabies in the amhara region of northern Ethiopia: a cross-sectional study of prevalence, determinants, clinical presentation and community knowledge","volume":"13","author":"Yirgu","year":"2023","journal-title":"BMJ Open"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices\u2013modeling studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jval.2012.04.012","article-title":"Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7","volume":"15","author":"Eddy","year":"2012","journal-title":"Value Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jval.2012.04.014","article-title":"Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6","volume":"15","author":"Briggs","year":"2012","journal-title":"Value Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1478-7547-11-6","article-title":"Consolidated health economic evaluation reporting standards (CHEERS) statement","volume":"11","author":"Husereau","year":"2013","journal-title":"Cost Eff Resour Alloc"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0004056","DOI":"10.1371\/journal.pntd.0004056","article-title":"Financial and economic costs of the elimination and eradication of onchocerciasis (river blindness) in Africa","volume":"9","author":"Kim","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0010147","DOI":"10.1371\/journal.pntd.0010147","article-title":"Costs of mass drug administration for scabies in Fiji","volume":"16","author":"Mow","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/0253-7613.48882","article-title":"Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies","volume":"41","author":"Bachewar","year":"2009","journal-title":"Indian J Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e15990","DOI":"10.1371\/journal.pone.0015990","article-title":"Control strategies for endemic childhood scabies","volume":"6","author":"Gilmore","year":"2011","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1006046","DOI":"10.1371\/journal.pcbi.1006046","article-title":"Scabies in residential care homes: modelling, inference and interventions for well-connected population sub-units","volume":"14","author":"Kinyanjui","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/bjd.18517","article-title":"In vitro ovicidal activity of current and under-development scabicides: which treatments kill scabies eggs?","volume":"182","author":"Bernigaud","year":"2020","journal-title":"Br J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mbs.2018.08.007","article-title":"A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination","volume":"309","author":"Lydeamore","year":"2019","journal-title":"Math Biosci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/trstmh\/trab114","article-title":"Broadening the range of use cases for ivermectin\u2013a review of the evidence","volume":"116","author":"Kositz","year":"2022","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B28","article-title":"Demographic and Social Statistics. Demographic Yearbook 2020","year":""},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8866639","article-title":"Compliance to a five-year biannual ivermectin treatment for onchocerciasis elimination and its determinants among adults in the bench Maji zone, southwest Ethiopia: a community-based cross-sectional study","author":"Kifle","year":"2021","journal-title":"J Parasitol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0004151","DOI":"10.1371\/journal.pntd.0004151","article-title":"Impact of an ivermectin mass drug administration on scabies prevalence in a remote Australian aboriginal community","volume":"9","author":"Kearns","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with endemic disease","volume":"73","author":"Romani","year":"2015","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jinf.2004.08.033","article-title":"Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature","volume":"50","author":"Roberts","year":"2005","journal-title":"J Infect"}],"container-title":["Frontiers in Health Services"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2024.1279762\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:56:52Z","timestamp":1726649812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2024.1279762\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":32,"alternative-id":["10.3389\/frhs.2024.1279762"],"URL":"https:\/\/doi.org\/10.3389\/frhs.2024.1279762","relation":{},"ISSN":["2813-0146"],"issn-type":[{"value":"2813-0146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"article-number":"1279762"}}